Back to Search Start Over

Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis

Authors :
Thiago Quinaglia
Carlos Gongora
Magid Awadalla
Malek Z.O. Hassan
Amna Zafar
Zsofia D. Drobni
Syed S. Mahmood
Lili Zhang
Otavio R. Coelho-Filho
Giselle A. Suero-Abreu
Muhammad A. Rizvi
Gagan Sahni
Anant Mandawat
Eduardo Zatarain-Nicolás
Michael Mahmoudi
Ryan Sullivan
Sarju Ganatra
Lucie M. Heinzerling
Franck Thuny
Stephane Ederhy
Hannah K. Gilman
Supraja Sama
Sofia Nikolaidou
Ana González Mansilla
Antonio Calles
Marcella Cabral
Francisco Fernández-Avilés
Juan José Gavira
Nahikari Salterain González
Manuel García de Yébenes Castro
Ana Barac
Jonathan Afilalo
Daniel A. Zlotoff
Leyre Zubiri
Kerry L. Reynolds
Richard Devereux
Judy Hung
Michael H. Picard
Eric H. Yang
Dipti Gupta
Caroline Michel
Alexander R. Lyon
Carol L. Chen
Anju Nohria
Michael G. Fradley
Paaladinesh Thavendiranathan
Tomas G. Neilan
Source :
JACC. Cardiovascular imaging, vol 15, iss 11
Publication Year :
2022
Publisher :
eScholarship, University of California, 2022.

Abstract

Global circumferential strain (GCS) and global radial strain (GRS) are reduced with cytotoxic chemotherapy. There are limited data on the effect of immune checkpoint inhibitor (ICI) myocarditis on GCS and GRS.This study aimed to detail the role of GCS and GRS in ICI myocarditis.In this retrospective study, GCS and GRS from 75 cases of patients with ICI myocarditis and 50 ICI-treated patients without myocarditis (controls) were compared. Pre-ICI GCS and GRS were available for 12 cases and 50 controls. Measurements were performed in a core laboratory blinded to group and time. Major adverse cardiovascular events (MACEs) were defined as a composite of cardiogenic shock, cardiac arrest, complete heart block, and cardiac death.Cases and controls were similar in age (66 ± 15 years vs 63 ± 12 years; P = 0.20), sex (male: 73% vs 61%; P = 0.20) and cancer type (P = 0.08). Pre-ICI GCS and GRS were also similar (GCS: 22.6% ± 3.4% vs 23.5% ± 3.8%; P = 0.14; GRS: 45.5% ± 6.2% vs 43.6% ± 8.8%; P = 0.24). Overall, 56% (n=42) of patients with myocarditis presented with preserved left ventricular ejection fraction (LVEF). GCS and GRS were lower in myocarditis compared with on-ICI controls (GCS: 17.5% ± 4.2% vs 23.6% ± 3.0%; P< 0.001; GRS: 28.6% ± 6.7% vs 47.0% ± 7.4%; P< 0.001). Over a median follow-up of 30days, 28 cardiovascular events occurred. A GCS (HR: 4.9 [95%CI: 1.6-15.0]; P = 0.005) and GRS (HR: 3.9 [95%CI: 1.4-10.8]; P = 0.008) below the median was associated with an increased event rate. In receiver-operating characteristic (ROC) curves, GCS (AUC: 0.80 [95%CI: 0.70-0.91]) and GRS (AUC: 0.76 [95%CI: 0.64-0.88]) showed better performance than cardiac troponin T (cTnT) (AUC: 0.70 [95%CI: 0.58-0.82]), LVEF (AUC: 0.69 [95%CI: 0.56-0.81]), and age (AUC: 0.54 [95%CI: 0.40-0.68]). Net reclassification index and integrated discrimination improvement demonstrated incremental prognostic utility of GRS over LVEF (P = 0.04) and GCS over cTnT (P = 0.002).GCS and GRS are lower in ICI myocarditis, and the magnitude of reduction has prognostic significance.

Details

Database :
OpenAIRE
Journal :
JACC. Cardiovascular imaging, vol 15, iss 11
Accession number :
edsair.doi.dedup.....d7457fb3fd369ec6430cb100a58c3fae